53
total announcements
KRONOX.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹741 Cr
P/E (TTM)
25.8
EPS (TTM)
₹7.73
52W Low
₹96.00
52W High
₹227.74
Dividend Yield
0.25%
Beta
0.89
Price / Book
6.3
Debt / Equity
1.4
Revenue (TTM)
₹105 Cr
Gross Margin
53.66%
Operating Margin
30.11%
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Resignation of an Independent Director of the company w.e.f. September 29, 2026. The company has received an intimation from the Sellers that the Sale Shares have been transferred to the Purchaser on September 29, 2026. The Board has approved the appointment of new directors and the Chief Financial Officer.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Resignation of Mr. Ketan Ramani & Mr. Pritesh Ramani as Executive Director of the company w.e.f. September 29, 2026. The company has received an intimation from the Sellers, pursuant to the provisions of Regulations 30 and 30A of the Listing Regulations, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The board of directors of the Company has approved the appointment of new directors and the transfer of Sale Shares from the Sellers to the Purchaser.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Resignation of Mrs. Krutika Negandhi as Independent Director of the company w.e.f. September 29, 2026. The company has also received an intimation from the Sellers, pursuant to the provisions of Regulations 30 and 30A of the Listing Regulations, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The Board has approved the appointment of new directors and the transfer of Sale Shares.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Resignation of MR. Satish Kumar as Independent Director of the company w.e.f. September 29, 2026. The company has also received an intimation from the Sellers, pursuant to the provisions of Regulations 30 and 30A of the Listing Regulations, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The board of directors of the Company has approved the appointment of new directors and the transfer of Sale Shares.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Resignation of Mr. Pritesh Ramani as Executive Director of the company w.e.f. September 29, 2026. The company has also received an intimation from the Sellers, that the Sellers have transferred the Sale Shares to the Purchaser on September 29, 2026. The board of directors of the Company has approved the appointment of new directors and the transfer of Sale Shares.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the resignation of Mr. Jogindersingh Jaswal as Chairman & Managing Director of the company, effective September 29, 2026.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange about change in Management, including the appointment of new directors and the transfer of shares from the Sellers to the Purchaser.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding 'Intimation under Regulation 31(A) of SEBI (LODR) Regulations, 2015'. The company has completed the transfer of 2,38,44,000 equity shares representing 64.26% of the total paid-up equity share capital from the sellers to the acquirer. The acquirer has acquired control of the company and has become the promoter. The erstwhile promoter/promoter group intends to cease to be members of the promoter/promoter group and re-classify as public.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on September 29, 2026. The company has received an intimation from the Sellers that they have transferred the Sale Shares to the Purchaser on September 29, 2026. The Sellers collectively hold 36,90,000 equity shares aggregating to 9.95% of the voting share capital of the Company. The board of directors has approved the appointment of new directors and the Chief Financial Officer.
Kronox Lab Sciences Limited
Indo Borax & Chemicals Ltd has submitted a disclosure under SEBI Takeover Regulations to the NSE, as per Regulation 18(6) of the SEBI (SAST) Regulations, 2011.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from October 1, 2026, for all designated persons until the announcement of unaudited financial results for the quarter and half year ending September 30, 2026.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has submitted the voting results and combined scrutinizer's report for its 17th Annual General Meeting held on September 16, 2026. The meeting passed four resolutions, including the appointment of a director and the declaration of a final dividend of Rs. 0.50 per equity share for the financial year 2025-26.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding voting results of Annual General Meeting held on August 18, 2025. The company has passed four resolutions, including the appointment of a director in place of Mr. [Name], and declared a final dividend of Rs. 0.50/- per equity share for the financial year 2025-26.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited held its 17th Annual General Meeting on September 16, 2026, through video conferencing. The meeting was attended by directors, key managerial personnel, and auditors. The company secretary welcomed shareholders and introduced the board members, invitees, and auditors. The chairman then welcomed the members and started the formal proceedings. The company secretary briefed the members on the arrangements made for the meeting, including the facility to participate and vote through video conferencing. The statutory registers under the Companies Act, 2013 were available for inspection to the members at the registered office of the company.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has received a draft letter of offer from IIFL Capital Services Limited on behalf of Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited for an open offer to acquire up to 95,70,000 equity shares, representing 25.79% of the voting share capital, at ₹157.27 per offer share.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange about a copy of newspaper publication for notice of 17th AGM to be held on September 16, 2026.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding the publication of a Detailed Public Statement (DPS) in connection with the open offer to the shareholders of the company.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has submitted a detailed public statement to the Exchange regarding SEBI (SAST) Regulations, 2011 as amended.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has announced the record date for the payment of final dividend for FY-25-26 as September 09, 2026.
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited has informed the Exchange regarding Notice of 17th Annual General Meeting to be held on September 16, 2026, through Video Conferencing/Audio-Visual Means. The meeting will consider and adopt the Audited Standalone Financial Statement of the Company for the financial year ended March 31, 2026, and other business.